Enzymology in Drug Discovery

Enzymes are the proteins in the drug design that act as drug targets for the diseases in the process of drug discovery and development. There are number of drug targets involved in the designing of the drug.

Drug target as a nucleic acid or a protein (e.g. an enzyme, a receptor) whose activity can be modified by a drug. The drug can be a small-molecular-weight chemical compound or a biological, such as an antibody or a recombinant protein. The drug target should have been shown to be effective/mechanistically involved in the disease by relevant in vitro or in vivo models.

  • Drug designing using enzymes
  • Drug development using enzymes
  • Drug modelling
  • Drug targeting

Related Conference of Enzymology in Drug Discovery

September 18-20, 2017

9th International Conference on Structural Biology

Zurich, Switzerland
September 28-29, 2017

2nd International Conference on Biochemistry

Dubai, UAE
October 16-17, 2017

3rd Annual Congress on Bioscience

Dubai,UAE
October 18-19, 2017

10th Annual Chemistry Congress

Osaka, Japan
October 30 - November 01, 2017

3rd International Conference on Transcriptomics

Bangkok, Thailand
November 8-9, 2017

International Summit on Nanotechnology and Medical Robots

New Orleans, Louisiana, USA
November 13-14, 2017

9th International Conference on Bioinformatics

Paris, France
19-20 March ,2018

23rd World Cardiology Conference

Dubai,UAE
August 06-07, 2018

18th International Conference on Pediatrics Health

Madrid, Spain
July 16-18, 2018

World Congress on Green Chemistry and Green Engineering

Melbourne, Australia
August 22-23, 2018

5th Asia Pacific Gynecology and Obstetrics Congress

Tokyo, Japan
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy

Enzymology in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in